Pharmaceutical

China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor

The China NMPA has granted clearance for the investigational new drug (IND) application of Guangzhou Fermion Technology’s FZ007-119.

Feb 6, 2024 - 18:00
China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor
The China NMPA has granted clearance for the investigational new drug (IND) application of Guangzhou Fermion Technology’s FZ007-119.
Read the original article

Tags:

Previous Article

Mithra sets out plan to rescue cash runway

Next Article

J&J touts success of nipocalimab in two rare disease trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Report: Measles cases and deaths increase worldwide, as childhood vaccinations rates decline

Report: Measles cases and deaths increase worldwide, as...

Nov 17, 2023

STAT+: Wegovy cardiovascular study has doctors seeing new possibilities in weight loss drug

STAT+: Wegovy cardiovascular study has doctors seeing n...

Aug 9, 2023

Galapagos enters deal to boost decentralised CAR-T therapy production

Galapagos enters deal to boost decentralised CAR-T ther...

May 19, 2024